Table 1 Tumor samples with an ETS binding site duplication in the TERT promoter
Duplicated Region1 | Duplicated Sequence | Insert Size (bp) | Insert Position5 | Other Acquired ETS Variants | Age | Race | Sex | Cancer Type | Tumor Type | Dataset | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Start | End | ||||||||||
c.-100_-79 | GGGCGGGGCCGCGGAAAGGAAG | 22 | 1295182 | 1295183 | NA | NA | NA | NA | Glioblastoma Multiforme | NA | Pierini et al. |
c.-100_-792 | GGGCGGGGCCGCGGAAAGGAAG | 22 | 1295182 | 1295183 | None | 54 | NA | Male | Glioblastoma Multiforme | NA | UCSF500 |
c.-100_-79 | GGGCGGGGCCGCGGAAAGGAAG | 22 | 1295182 | 1295183 | G228A | 29 | NA | Female | Squamous Cell Carcinoma | Metastasis | UCSF500 |
c.-100_-79 | GGGCGGGGCCGCGGAAAGGAAG | 22 | 1295182 | 1295183 | None | 68 | White | Male | Duodenal Adenocarcinoma | Metastasis | GENIE |
c.-100_-793 | GGGCGGGGCCGCGGAAAGGAAG | 22 | 1295182 | 1295183 | None | 48 | NA | Male | Glioblastoma Multiforme | Primary | UCSF500 |
c.-100_-793 | GGGCGGGGCCGCGGAAAGGAAG | 22 | 1295182 | 1295183 | None | 48 | NA | Male | Glioblastoma Multiforme | Primary | UCSF500 |
c.-100_-793 | GGGCGGGGCCGCGGAAAGGAAG | 22 | 1295182 | 1295183 | None | 48 | NA | Male | Glioblastoma Multiforme | Recurrent | UCSF500 |
c.‐104_‐83 | GGGGCCGCGGAAAGGAAGGGGA | 22 | 1295186 | 1295187 | None | 42 | Asian | Male | Oral Cavity Squamous Cell Carcinoma | Metastasis | GENIE |
c.‐104_‐83 | GGGGCCGCGGAAAGGAAGGGGA | 22 | 1295186 | 1295187 | None | 50 | White | Male | Bladder Urothelial Carcinoma | Primary | GENIE |
c.‐104_‐83 | GGGGCCGCGGAAAGGAAGGGGA | 22 | 1295186 | 1295187 | None | 68 | Black | Male | Hepatocellular Carcinoma | Primary | GENIE |
c.‐104_‐83 | GGGGCCGCGGAAAGGAAGGGGA | 22 | 1295186 | 1295187 | NA | NA | NA | NA | Papillary Thyroid Cancer | NA | Panebianco et al. |
c.-110_-89 | GCGGAAAGGAAGGGGAGGGGCT | 22 | 1295192 | 1295193 | None | 48 | Asian | Female | Malignant Phyllodes Tumor of the Breast | Primary | GENIE |
c.-110_-89 | GCGGAAAGGAAGGGGAGGGGCT | 22 | 1295192 | 1295193 | None | 64 | White | Male | Glioblastoma Multiforme | Primary | GENIE |
c.-110_-89 | GCGGAAAGGAAGGGGAGGGGCT | 22 | 1295192 | 1295193 | None | 65 | NA | Male | Glioblastoma Multiforme | Primary | GENIE |
c.-110_-894 | GCGGAAAGGAAGGGGAGGGGCTA | 23 | 1295192 | 1295193 | None | 69 | White | Female | Papillary Thyroid Cancer | Metastasis | GENIE |
c.-110_-894 | GCGGAAAGGAAGGGGAGGGGCTA | 23 | 1295192 | 1295193 | None | 72 | White | Female | Poorly Differentiated Thyroid Cancer | Metastasis | GENIE |
c.-110_-89 | GCGGAAAGGAAGGGGAGGGGCT | 22 | 1295192 | 1295193 | NA | NA | NA | NA | Glioblastoma Multiforme | NA | Pierini et al. |
c.-116_-96 | GGAAGGGGAGGGGCTGGGAGG | 21 | 1295199 | 1295200 | None | 64 | White | Male | Hepatocellular Carcinoma | Primary | GENIE |
c.-120_-96 | GGAAGGGGAGGGGCTGGGAGGGCCC | 25 | 1295199 | 1295200 | None | 80 | NA | Female | Poorly Differentiated Thyroid Cancer | NA | UCSF500 |
c.-120_-96 | GGAAGGGGAGGGGCTGGGAGGGCCC | 25 | 1295199 | 1295200 | None | 68 | White | Male | Hepatocellular Carcinoma | Primary | GENIE |
c.-125_-106 | GGGGCTGGGCTGGGAGGGCCCGGAA | 25 | 1295228 | 1295229 | G228A | 69 | White | Male | Bladder Urothelial Carcinoma | Metastasis | GENIE |